LI
GILD icon

LMCG Investments’s Gilead Sciences GILD Stock Holding History

LMCG Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
17,512
-2
-0% -$264 0.12% 132
2026
Q1 		$2.44M Sell
17,514
-90
-0.5% -$12.6K 0.15% 121
2025
Q4 		$2.16M Sell
17,604
-122
-0.7% -$14.8K 0.12% 127
2025
Q3 		$1.97M Sell
17,726
-71
-0.4% -$8.07K 0.12% 130
2025
Q2 		$1.97M Sell
17,797
-13,316
-43% -$1.42M 0.12% 132
2025
Q1 		$3.49M Sell
31,113
-71,912
-70% -$7.42M 0.23% 116
2024
Q4 		$9.52M Buy
103,025
+650
+0.6% +$58.5K 0.58% 63
2024
Q3 		$8.58M Sell
102,375
-381
-0.4% -$29.1K 0.52% 76
2024
Q2 		$7.05M Sell
102,756
-971
-0.9% -$64.8K 0.41% 85
2024
Q1 		$7.6M Sell
103,727
-790
-0.8% -$60.7K 0.45% 82
2023
Q4 		$8.47M Sell
104,517
-772
-0.7% -$60.1K 0.52% 70
2023
Q3 		$7.89M Sell
105,289
-1,026
-1% -$78.9K 0.53% 63
2023
Q2 		$8.19M Sell
106,315
-725
-0.7% -$57.8K 0.53% 65
2023
Q1 		$8.88M Sell
107,040
-7,363
-6% -$610K 0.59% 61
2022
Q4 		$9.82M Sell
114,403
-5,753
-5% -$456K 0.69% 44
2022
Q3 		$7.41M Sell
120,156
-1,587
-1% -$100K 0.54% 56
2022
Q2 		$7.53M Sell
121,743
-635
-0.5% -$39.3K 0.52% 62
2022
Q1 		$7.28M Buy
+122,378
New +$7.82M 0.42% 77
2015
Q3 		$14.2M Sell
144,684
-18,853
-12% -$2.09M 0.3% 106
2015
Q2 		$19.1M Sell
163,537
-7,468
-4% -$816K 0.41% 68
2015
Q1 		$16.8M Sell
171,005
-1,426
-0.8% -$145K 0.35% 85
2014
Q4 		$16.3M Sell
172,431
-1,716
-1% -$177K 0.36% 96
2014
Q3 		$18.5M Sell
174,147
-9,054
-5% -$887K 0.42% 66
2014
Q2 		$15.2M Sell
183,201
-15,895
-8% -$1.24M 0.33% 112
2014
Q1 		$14.1M Sell
199,096
-8,586
-4% -$673K 0.31% 113
2013
Q4 		$15.6M Sell
207,682
-4,580
-2% -$319K 0.33% 108
2013
Q3 		$13.3M Sell
212,262
-7,879
-4% -$471K 0.32% 117
2013
Q2 		$11.3M Buy
+220,141
New +$11.5M 0.3% 125

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LMCG Investments's GILD Position: Q2 2026 in Review

LMCG Investments reduced its Gilead Sciences (GILD) stake by 0.01% in Q2 2026, selling an estimated $264 and leaving 17,512 shares worth $2.21M. The position accounts for 0.12% of the portfolio, ranked #132.

LMCG Investments first reported a position in GILD in Q2 2013 and has held it in 28 quarters since. The position peaked at $19.1M in Q2 2015. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LMCG Investments held 17,512 shares of Gilead Sciences worth $2.21M as of Q2 2026.
  • LMCG Investments sold 2 Gilead Sciences shares in Q2 2026, an estimated $264.
  • Gilead Sciences made up 0.12% of LMCG Investments's portfolio in Q2 2026, its #132 holding.
  • LMCG Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 28 quarters since.
  • LMCG Investments's Gilead Sciences position peaked at $19.1M in Q2 2015.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.